HI
BMY icon

Hudock Inc’s Bristol-Myers Squibb BMY Stock Holding History

Hudock Inc’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$302K Sell
4,984
-251
-5% -$14.6K 0.04% 152
2025
Q4 		$282K Sell
5,235
-187
-3% -$9K 0.04% 160
2025
Q3 		$245K Buy
5,422
+8
+0.1% +$374 0.04% 175
2025
Q2 		$251K Buy
5,414
+7
+0.1% +$344 0.04% 163
2025
Q1 		$330K Sell
5,407
-55
-1% -$3.21K 0.06% 126
2024
Q4 		$309K Sell
5,462
-357
-6% -$19.9K 0.05% 129
2024
Q3 		$301K Buy
5,819
+408
+8% +$19.1K 0.05% 134
2024
Q2 		$225K Buy
5,411
+7
+0.1% +$313 0.04% 156
2024
Q1 		$293K Sell
5,404
-785
-13% -$40K 0.06% 112
2023
Q4 		$318K Buy
6,189
+7
+0.1% +$367 0.07% 114
2023
Q3 		$359K Buy
6,182
+6
+0.1% +$368 0.09% 95
2023
Q2 		$395K Buy
6,176
+5
+0.1% +$335 0.09% 95
2023
Q1 		$428K Buy
6,171
+254
+4% +$17.9K 0.11% 87
2022
Q4 		$426K Buy
5,917
+1
+0% +$75 0.15% 83
2022
Q3 		$420K Buy
5,916
+501
+9% +$36.3K 0.14% 83
2022
Q2 		$417K Sell
5,415
-200
-4% -$15.2K 0.14% 83
2022
Q1 		$410K Sell
5,615
-48
-0.8% -$3.22K 0.11% 93
2021
Q4 		$353K Sell
5,663
-28
-0.5% -$1.64K 0.1% 109
2021
Q3 		$336K Sell
5,691
-742
-12% -$48.9K 0.1% 110
2021
Q2 		$429K Buy
6,433
+8
+0.1% +$522 0.13% 94
2021
Q1 		$405K Sell
6,425
-238
-4% -$14.8K 0.13% 92
2020
Q4 		$413K Buy
6,663
+294
+5% +$18.1K 0.13% 84
2020
Q3 		$383K Buy
6,369
+2
+0% +$120 0.14% 79
2020
Q2 		$374K Buy
6,367
+101
+2% +$6.04K 0.14% 79
2020
Q1 		$349K Buy
6,266
+79
+1% +$4.83K 0.14% 76
2019
Q4 		$391K Sell
6,187
-198
-3% -$11.3K 0.13% 77
2019
Q3 		$323K Buy
6,385
+1
+0% +$47 0.11% 78
2019
Q2 		$289K Sell
6,384
-4,814
-43% -$224K 0.1% 83
2019
Q1 		$534K Buy
11,198
+1
+0% +$50 0.19% 60
2018
Q4 		$570K Sell
11,197
-79
-0.7% -$4.25K 0.24% 57
2018
Q3 		$700K Buy
11,276
+1
+0% +$59 0.27% 54
2018
Q2 		$623K Buy
11,275
+94
+0.8% +$5.08K 0.25% 63
2018
Q1 		$707K Sell
11,181
-719
-6% -$46.3K 0.29% 63
2017
Q4 		$729K Buy
11,900
+45
+0.4% +$2.81K 0.32% 44
2017
Q3 		$755K Buy
11,855
+80
+0.7% +$4.67K 0.35% 38
2017
Q2 		$656K Buy
11,775
+49
+0.4% +$2.67K 0.34% 39
2017
Q1 		$637K Sell
11,726
-170
-1% -$9.32K 0.34% 41
2016
Q4 		$695K Sell
11,896
-600
-5% -$32.8K 0.39% 37
2016
Q3 		$673K Buy
12,496
+1,005
+9% +$64.6K 0.38% 42
2016
Q2 		$845K Buy
11,491
+17
+0.1% +$1.2K 0.46% 36
2016
Q1 		$732K Sell
11,474
-18
-0.2% -$1.14K 0.41% 35
2015
Q4 		$790K Buy
11,492
+36
+0.3% +$2.38K 0.35% 34
2015
Q3 		$678K Buy
11,456
+36
+0.3% +$2.28K 0.32% 34
2015
Q2 		$759K Buy
11,420
+37
+0.3% +$2.44K 0.35% 33
2015
Q1 		$734K Buy
11,383
+41
+0.4% +$2.57K 0.33% 37
2014
Q4 		$670K Buy
11,342
+42
+0.4% +$2.37K 0.31% 43
2014
Q3 		$578K Buy
11,300
+98
+0.9% +$4.89K 0.36% 51
2014
Q2 		$543K Buy
11,202
+121
+1% +$5.96K 0.62% 35
2014
Q1 		$576K Buy
11,081
+118
+1% +$6.28K 0.48% 30
2013
Q4 		$583K Buy
10,963
+41
+0.4% +$2.09K 0.49% 29
2013
Q3 		$505K Buy
10,922
+48
+0.4% +$2.11K 0.49% 29
2013
Q2 		$486K Buy
+10,874
New +$472K 0.72% 30

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Hudock Inc's BMY Position: Q1 2026 in Review

Hudock Inc reduced its Bristol-Myers Squibb (BMY) stake by 4.8% in Q1 2026, selling an estimated $14.6K and leaving 4,984 shares worth $302K. The position accounts for 0.04% of the portfolio, ranked #152.

Hudock Inc first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $845K in Q2 2016. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Hudock Inc held 4,984 shares of Bristol-Myers Squibb worth $302K as of Q1 2026.
  • Hudock Inc sold 251 Bristol-Myers Squibb shares in Q1 2026, an estimated $14.6K.
  • Bristol-Myers Squibb made up 0.04% of Hudock Inc's portfolio in Q1 2026, its #152 holding.
  • Hudock Inc first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • Hudock Inc's Bristol-Myers Squibb position peaked at $845K in Q2 2016.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Hudock Inc's 13F filing for Q1 2026, filed 13 May 2026.